BackGreenLight Biosciences Overview

GreenLight Biosciences Accounts Payable

GreenLight Biosciences's accounts payable is $1.1M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$1.07M
82.26% YoYΔ $-4.98M vs prior year quarter

Peer average

Loading

GreenLight Biosciences Accounts Payable History

Loading

GreenLight Biosciences vs. peers: Accounts Payable Comparison

Loading

GreenLight Biosciences Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GreenLight Biosciences (GRNA) FAQ

As of the most recent data (March 2023), GRNA shows a accounts payable of $1.1M. That compares with $6M in the prior-year period — down 82.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GRNA's accounts payable is now $1.1M (was $6M) — a 82.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether GreenLight Biosciences is outperforming or lagging.

Tracking GRNA's accounts payable over time shows whether GreenLight Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1M That compares with $6M in the prior-year period — down 82.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has GreenLight Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $1.1M) with ownership activity and broader fundamentals.